Metrikler
Yayın
506
Açık Erişim
144
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
2005 - 2008
2005 - 2008Tıpta Yandal Uzmanlık
Hacettepe Üniversitesi, Tıp Fakültesi, Romatoloji Bd, Türkiye
2000 - 2005
2000 - 2005Tıpta Uzmanlık
Hacettepe Üniversitesi, Tıp Fakülitesi, İç Hastalıkları, Türkiye
1994 - 2000
1994 - 2000Lisans
Hacettepe Üniversitesi, Tıp Fakültesi, Türkiye
Araştırma Alanları
Tıp
Dahili Tıp Bilimleri
İç Hastalıkları
İmmünoloji ve Romatoloji
Sağlık Bilimleri
Akademik Faaliyetlere Dayalı Araştırma Alanları
Avesis Araştırma Alanları
WoS Araştırma Alanları
Scopus Araştırma Alanları
Akademik Ünvanlar / Görevler
2018 - Devam Ediyor
2018 - Devam EdiyorProf. Dr.
Hacettepe Üniversitesi, Tıp Fakültesi (İngilizce), Dahili Tıp Bilimleri Bölümü
2012 - 2018
2012 - 2018Doç. Dr.
Hacettepe Üniversitesi, Tıp Fakültesi (İngilizce), Dahili Tıp Bilimleri Bölümü
2011 - 2012
2011 - 2012Öğretim Görevlisi Dr.
Hacettepe Üniversitesi, Tıp Fakültesi (İngilizce), Dahili Tıp Bilimleri Bölümü
Akademi Dışı Deneyim
2016 - Devam Ediyor
2016 - Devam EdiyorSenior Clinical Research Fellow
University of Cambridge, Senior Clinical Research Fellow
2010 - 2011
2010 - 2011Romatoloji Uzmanı
Diyarbakır Eğitim ve Araştırma Hastanesi, Romatoloji Uzmanı
2009 - 2010
2009 - 2010Romatoloji Uzmanı (Askerlik)
Gülhane Askeri Tıp Akademisi, Romatoloji Uzmanı (Askerlik)
2007 - 2007
2007 - 2007Musculoskeletal Ultrasonography Education
Politechnica della Marche University, Musculoskeletal Ultrasonography Education
Yönetilen Tezler
2016
2016Tıpta Uzmanlık
Sistemik sklerozlu hastalarda serum defensin düzeylerinin belirlenmesi
KARADAĞ Ö.
T.EMİROĞLU(Öğrenci)
Makaleler
Tümü (62)
SCI-E, SSCI, AHCI (53)
SCI-E, SSCI, AHCI, ESCI (56)
ESCI (3)
Scopus (59)
TRDizin (3)
Diğer Yayınlar (1)
2025
20251. Türkiye Romatoloji Derneği ANCA ilişkili (asosiye) vaskülitler hastalık yönetimi kılavuzu
Karadag O., Duran E., Dağlı P. A., Gerçik Ö., Kardaş R. C., sahin d., et al.
Ulusal Romatoloji Dergisi
, cilt.17, sa.3, ss.131-144, 2025 (Scopus, TRDizin)
2025
20252. A rare disease with many faces: a multicentre registry of IgG4-related disease in children
KAYA AKCA Ü., KÖSE H., Kurt T., Ulu K., Guliyeva V., Kilbas G., et al.
RHEUMATOLOGY
, sa.4, ss.2185-2192, 2025 (SCI-Expanded, Scopus)
2025
20253. Idiopathic polyarteritis nodosa-does it still exist? Viewpoint 2: idiopathic polyarteritis nodosa is rare, but still exists
KARADAĞ Ö.
RHEUMATOLOGY
, 2025 (SCI-Expanded, Scopus)
2025
20254. Relationship Between Ultrasound and Physical Examination in the Assessment of Enthesitis in Patients With Spondyloarthritis: Results From the DEUS Multicenter Study
Di Matteo A., Di Donato S., Smerilli G., Becciolini A., Camarda F., Cauli A., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.77, ss.22-33, 2025 (SCI-Expanded, Scopus)
2024
20245. Commentary on IgG4-related uveitis. A French cohort and literature review
EKİCİ M., KADAYIFÇILAR S., BEZCİ AYGÜN F., KARADAĞ Ö.
SEMINARS IN ARTHRITIS AND RHEUMATISM
, cilt.69, 2024 (SCI-Expanded, Scopus)
2024
20246. The impact of histopathological criteria for definite vasculitis in giant cell arteritis: retrospective analysis of temporal artery biopsies
Uzun G. S., GÖKÖZ Ö., ÖĞÜT B., HEPER A., Guresci S., KARDAŞ R. C., et al.
RHEUMATOLOGY INTERNATIONAL
, cilt.44, ss.2547-2554, 2024 (SCI-Expanded, Scopus)
2024
20247. Long-term follow-up of anti-TNF treatment in adult and pediatric DADA2 patients: Insights from real-world data
AYAN G., BAŞARAN H. Ö., FIRLATAN B., KILIÇ L., BİLGİNER Y., ALİKAŞİFOĞLU M., et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
, cilt.27, sa.11, 2024 (SCI-Expanded, Scopus)
2024
20248. Factors Associated with the Development of Anti-drug Antibodies to TNFi and the Consequences for Axial Spondyloarthritis: A Two-year Follow-up Study
Ediboglu E. D., Cinar M., KOZACI L. D., SOLMAZ D., Sargin G., KARADAĞ Ö., et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY
, cilt.11, sa.3, ss.364-370, 2024 (ESCI, TRDizin)
2024
20249. Comparison of the safety profile of tofacitinib and etanercept in rheumatoid arthritis patients aged 60 years and over: The real-life data from the HUR-BIO registry
SARIYILDIZ E., ÜNALDI E., KILIÇ L., KARADAĞ Ö., KALYONCU U., ERTENLİ A. İ., et al.
Acta Medica
, cilt.55, sa.3, ss.214-221, 2024 (TRDizin)
2024
202410. Assessment of venous disease with different venous disease specific scales in Behçet's disease patients with deep vein thrombosis
AKSOY A., Colak S., YAĞIZ B., COŞKUN B. N., Omma A., SARI A., et al.
PHLEBOLOGY
, cilt.39, ss.550-556, 2024 (SCI-Expanded, Scopus)
2024
202411. Orbital Pseudotumor in Granulomatosis with Polyangiitis. Interim Analysis of Clinical Outcomes from a European Collaborative Observational Study
Moroni L., Gallina G., Lanzillotta M., Maggioni S., Benanti G., Cariddi A., et al.
ARTHRITIS & RHEUMATOLOGY
, ss.5054-5057, 2024 (SCI-Expanded, Scopus)
2024
202412. Addressing Glucocorticoid-Related Problems with the Clinical Pharmacist Collaboration in Rheumatology Practice: A Prospective Follow-Up Study
Bahap-Kara M., SARIYILDIZ E., YARDIMCI G. K., KARADAĞ Ö., EKİNCİOĞLU A.
RHEUMATOLOGY AND THERAPY
, cilt.11, sa.4, ss.1043-1055, 2024 (SCI-Expanded, Scopus)
2024
202413. IMMUNOGLOBULIN G4-RELATED THORACIC DISEASE: CLINICAL AND RADIOLOGICAL FINDINGS OF A TURKISH COHORT
Alkan A., DURHAN G., YARDIMCI G. K., Sertcelik U. O., Farisogullari B., Ariyurek M., et al.
SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES
, cilt.41, sa.2, 2024 (SCI-Expanded, Scopus)
2024
202414. REAL-LIFE DATA COMPARING THE LONG-TERM OUTCOME AND TREATMENT IN ADULT AND PEDIATRIC DADA2 PATIENTS: SINGLE CENTER EXPERIENCE OVER 10 YEARS
Ayan G., BAŞARAN H. Ö., BÖLEK E. Ç., FIRLATAN YAZGAN B., Bulat B., BATU AKAL E. D., et al.
ANNALS OF THE RHEUMATIC DISEASES
, ss.1113-1114, 2024 (SCI-Expanded, Scopus)
2024
202415. LONG-TERM FOLLOW-UP AND RESULTS OF CHILDHOOD-ONSET ENTHESITIS-RELATED ARTHRITIS AND POLYARTHRITIS: HUR-BIO EXPERIENCE
Ata E. B., Kilic L., Bilgin E., Uzun G. S., Ayan G., Ekici M., et al.
ANNALS OF THE RHEUMATIC DISEASES
, 2024 (SCI-Expanded, Scopus)
2024
202416. CENTRAL NERVOUS SYSTEM INVOLVEMENT OF ANCA-ASSOCIATED VASCULITIS IN A SINGLE CENTER - HUVAC EXPERIENCE
Ozen N. P. A., Bilgin E., Duran E., TOPÇUOĞLU M. A., Arsava E. M., Gocmen R., et al.
ANNALS OF THE RHEUMATIC DISEASES
, 2024 (SCI-Expanded, Scopus)
2024
202417. REMARKING THE OSTEOPOROSIS IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS (AAV): DATA FROM EASTERN MEDITERRANEAN (TRVAS)
Yildirim T. D., Erpek E., Ulusoy B. O., Unaldi E., Cagdas O. S., Kardas R. C., et al.
ANNALS OF THE RHEUMATIC DISEASES
, 2024 (SCI-Expanded, Scopus)
2024
202418. DIFFERENCES IN THE CHARACTERISTICS OF D2T/ NOND2T-RA PATIENTS AND FACTORS ASSOCIATED WITH D2T-RA AT B/TSDMARD START
Eken A., Ayan G., Ozsoy Z., Uzun G. S., Ekici M., Unaldi E., et al.
ANNALS OF THE RHEUMATIC DISEASES
, 2024 (SCI-Expanded, Scopus)
2024
202419. Prospective assessment of glucocorticoid toxicity in rheumatology practice: a focus on the glucocorticoid toxicity index
Bahap-Kara M., SARIYILDIZ E., ZENGİN H. Y., KARADAĞ Ö., EKİNCİOĞLU A.
RHEUMATOLOGY
, sa.3, ss.1010-1018, 2024 (SCI-Expanded, Scopus)
2024
202420. Characteristics and outcome of ANCA-associated vasculitides induced by anti-thyroid drugs: a multicentre retrospective case-control study
Culerrier J., Nguyen Y., KARADAĞ Ö., SÖZEN ŞAHNE B., Yildrim T. D., Ögüt T. S., et al.
Rheumatology (United Kingdom)
, cilt.63, sa.4, ss.999-1006, 2024 (SCI-Expanded, Scopus)
2024
202421. Low relapse rate in patients with giant cell arteritis in a multi-centre retrospective Turkish Registry.
Alibaz-Öner F., Kelesoglu B., Balci M. A., Yardimci G. K., Armağan B., Kiliç L., et al.
Clinical and experimental rheumatology
, cilt.42, sa.4, ss.816-821, 2024 (SCI-Expanded, Scopus)
2024
202422. A close look at the nutritional status and mediterranean diet adherence in patients with behcet's syndrome
ERSOY N., BÖLEK E. Ç., Farisoǧullari B., Çinar N., Garipoǧlu G., Çolak S., et al.
Mediterranean Journal of Nutrition and Metabolism
, cilt.17, sa.1, ss.43-52, 2024 (ESCI, Scopus)
2024
202423. Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre study
Di Matteo A., Smerilli G., Di Donato S., Liu A. R., Becciolini A., Camarda F., et al.
Annals of the Rheumatic Diseases
, 2024 (SCI-Expanded, Scopus)
2024
202424. Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: Real life experience from the TReasure Registry
KARADAĞ Ö., Farisogullari B., YAĞIZ B., Erden A., Ademoglu Z., Kimyon G., et al.
Clinical and Experimental Rheumatology
, cilt.42, sa.1, ss.130-137, 2024 (SCI-Expanded, Scopus)
2024
202425. Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International Study
KARADAĞ Ö., BÖLEK E. Ç., AYAN G., Mohammad A. J., Grayson P. C., Pagnoux C., et al.
Arthritis and Rheumatology
, 2024 (SCI-Expanded, Scopus)
2024
202426. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS)
BİLGİN E., Demirci Yıldırım T., Özdemir Ulusoy B., Öğüt T. S., Karabacak M., Sadioğlu Çağdaş Ö., et al.
Internal and Emergency Medicine
, 2024 (SCI-Expanded, Scopus)
2024
202427. Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study
Geraldes R., Santos M., Ponte C., Craven A., Barra L., Robson J. C., et al.
Journal of Neurology
, 2024 (SCI-Expanded, Scopus)
2023
202328. Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study.
Can Bostan Ö., Duran E., Tuncay G., Cihanbeylerden M., Karadag Ö., Damadoglu E., et al.
The Journal of asthma : official journal of the Association for the Care of Asthma
, cilt.60, sa.5, ss.931-937, 2023 (SCI-Expanded, Scopus)
2023
202329. Vital corner of diagnostic challenge: eosinophilic granulomatosis with polyangiitis or COVID-19 pneumonia?
Duran E., Kilic L., Durhan G., Inkaya A. Ç., Guven G. S., Karakaya G., et al.
Annals of the rheumatic diseases
, cilt.82, sa.4, 2023 (SCI-Expanded, Scopus)
2022
202230. 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis.
Ponte C., Grayson P. C., Robson J. C., Suppiah R., Gribbons K. B., Judge A., et al.
Annals of the rheumatic diseases
, cilt.81, sa.12, ss.1647-1653, 2022 (SCI-Expanded, Scopus)
2022
202231. 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis.
Grayson P. C., Ponte C., Suppiah R., Robson J. C., Gribbons K. B., Judge A., et al.
Annals of the rheumatic diseases
, cilt.81, sa.12, ss.1654-1660, 2022 (SCI-Expanded, Scopus)
2022
202232. Reliability assessment of the definition of ultrasound enthesitis in SpA: results of a large, multicentre, international, web-based study
Di Matteo A., Cipolletta E., Castaniti G. M. D., Smerilli G., Airoldi C., Aydin S. Z., et al.
RHEUMATOLOGY
, cilt.61, ss.4863-4874, 2022 (SCI-Expanded, Scopus)
2022
202233. Recurrent Aphthous Stomatitis and Related Factors in Turkish Adult Population: A Striking Outcome of Cappadocia Chronic Diseases Epidemiological Study
ÇALIK BAŞARAN N., KALYONCU U., KARADAĞ Ö., AKDOĞAN A., ERDEN A., KILIÇ L., et al.
Cumhuriyet Tıp Dergisi (ELEKTRONİK) , cilt.44, sa.3, ss.233-238, 2022 (Hakemli Dergi)
2022
202234. Biologics for immunoglobulin A vasculitis: targeting vasculitis or comorbid disease?
Farisogullari B., Cuceoglu M., Oral H., Yardimci G. K., Bilginer Y., Ozen S., et al.
Internal and emergency medicine
, cilt.17, sa.6, ss.1599-1608, 2022 (SCI-Expanded, Scopus)
2022
202235. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis.
Grayson P. C., Ponte C., Suppiah R., Robson J. C., Craven A., Judge A., et al.
Annals of the rheumatic diseases
, cilt.81, sa.3, ss.309-314, 2022 (SCI-Expanded, Scopus)
2022
202236. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis.
Suppiah R., Robson J. C., Grayson P. C., Ponte C., Craven A., Khalid S., et al.
Annals of the rheumatic diseases
, cilt.81, sa.3, ss.321-326, 2022 (SCI-Expanded, Scopus)
2022
202237. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis.
Robson J. C., Grayson P. C., Ponte C., Suppiah R., Craven A., Judge A., et al.
Annals of the rheumatic diseases
, cilt.81, sa.3, ss.315-320, 2022 (SCI-Expanded, Scopus)
2022
202238. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
Ytterberg S. R., Bhatt D. L., Mikuls T. R., Koch G. G., Fleischmann R., Rivas J. L., et al.
The New England journal of medicine
, cilt.386, sa.4, ss.316-326, 2022 (SCI-Expanded, Scopus)
2022
202239. Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO Registry.
Farisoğulları B., Yardımcı G. K., Sarı A., Bilgin E., Bölek E. Ç., Duran E., et al.
Clinical and experimental rheumatology
, cilt.40, sa.1, ss.112-119, 2022 (SCI-Expanded, Scopus)
2021
202140. Successful treatment of penile Mondor's disease with infliximab in a patient with Behçet's disease.
Özbek D. A., Bilgin E., Onur M. R., Karadağ Ö., Kiraz S.
Rheumatology (Oxford, England)
, cilt.60, sa.11, 2021 (SCI-Expanded, Scopus)
2021
202141. Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis.
Lanzillotta M., Della-Torre E., Wallace Z. S., Stone J. H., Karadag Ö., Fernández-Codina A., et al.
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
, cilt.21, sa.7, ss.1395-1401, 2021 (SCI-Expanded, Scopus)
2021
202142. Spinal and cerebral hematoma in systemic lupus erythematosus and antiphospholipid syndrome: is drug interaction the culprit?
DURAN E., BİLGİN E., BÖLEK E. Ç., FIRAT O., BULUT E. G., KALYONCU U., et al.
DRUG METABOLISM AND PERSONALIZED THERAPY
, cilt.36, sa.2, ss.169-172, 2021 (Scopus)
2021
202143. Is Takayasu's arteritis more severe in children?
Bolek E., Kaya A., Sari A., Sag E., Demir S., Kilic L., et al.
Clinical and experimental rheumatology
, sa.2, ss.32-38, 2021 (SCI-Expanded, Scopus)
2021
202144. Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes.
Monti S., Craven A., Klersy C., Montecucco C., Caporali R., Watts R., et al.
Rheumatology (Oxford, England)
, cilt.60, sa.2, ss.617-628, 2021 (SCI-Expanded, Scopus)
2021
202145. Mediastinal mass in a patient with rheumatoid arthritis: lymphoid cystic thymic hyperplasia
ORAL H., BİLGİN E., YILDIRIM S., ÖNDER S. Ç., DEMİRKAZIK F., Serkan U., et al.
RHEUMATOLOGY ADVANCES IN PRACTICE
, cilt.5, sa.2, 2021 (ESCI, Scopus)
2020
202046. Predictive factors for work-day loss in Behcet's syndrome: A multi-center study
MUMCU G., Yay M., Aksoy A., Tas M. N., ARMAĞAN B., SARI A., et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
, cilt.23, sa.2, ss.240-246, 2020 (SCI-Expanded, Scopus)
2020
202047. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2
Ozen S., Bilginer Y., Batu E., Taşkıran E., Özkara H. A., Ünal Ş., et al.
JOURNAL OF RHEUMATOLOGY
, cilt.47, sa.1, ss.117-125, 2020 (SCI-Expanded, Scopus)
2019
201948. Two cases of glutaric aciduria type II: how to differentiate from inflammatory myopathies?
Koca M., Erden A., Armagan B., Sari A., Yildiz F., Ozdamar S., et al.
Acta clinica Belgica
, cilt.74, sa.6, ss.451-455, 2019 (SCI-Expanded, Scopus)
2019
201949. Comment on: Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritisanti-TNF
Duran E., Yildirim B. E. S., KARADAĞ Ö.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.5, sa.9, 2019 (SCI-Expanded, Scopus)
2019
201950. Oral ulcer activity assessment with the composite index according to different treatment modalities in Behcet's syndrome: a multicentre study
Mumcu G., Karacayli U., Yay M., Aksoy A., Tas M. N., Armagan B., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.37, sa.6, ss.98-104, 2019 (SCI-Expanded, Scopus)
2018
201851. Cross-phenotype analysis of Immunochip data identifies KDM4C as a relevant locus for the development of systemic vasculitis.
Ortiz-Fernández L., Carmona F. D., López-Mejías R., González-Escribano M. F., Lyons P. A., Morgan A. W., et al.
Annals of the rheumatic diseases
, cilt.77, sa.4, ss.589-595, 2018 (SCI-Expanded, Scopus)
2017
201752. Assessment of Disease Activity in Large-vessel Vasculitis: Results of an International Delphi Exercise.
Aydin S. Z., Direskeneli H., Merkel P. A., Ytterberg S., Blockmans D., Sato E. I., et al.
The Journal of rheumatology
, cilt.44, sa.12, ss.1928-1932, 2017 (SCI-Expanded, Scopus)
2017
201753. Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy.
Carmona F. D., Coit P., Saruhan-Direskeneli G., Hernández-Rodríguez J., Cid M. C., Solans R., et al.
Scientific reports
, cilt.7, ss.43953, 2017 (SCI-Expanded, Scopus)
2013
201354. Systemic involvements and preferred treatments in a large cohort of Behçet's disease.
Yilmaz S., Karadag Ö., Yazisiz V., Altun B., Gezer M., Karaman M., et al.
Rheumatology international
, cilt.33, sa.12, ss.3025-30, 2013 (SCI-Expanded, Scopus)
2013
201355. The presence of MEFV gene mutations in patients with primary osteoarthritis who require surgery.
Yilmaz S., Erdem H., Tunay S., Torun D., Genc H., Tunca Y., et al.
The Korean journal of internal medicine
, cilt.28, sa.5, ss.594-8, 2013 (Scopus)
2013
201356. The factors considered as trigger for the attacks in patients with familial Mediterranean fever
Karadag Ö., TUFAN A., Yazisiz V., Ureten K., Yilmaz S., Cinar M., et al.
RHEUMATOLOGY INTERNATIONAL
, cilt.33, sa.4, ss.893-897, 2013 (SCI-Expanded, Scopus)
2013
201357. Relationship of ultrasonographic findings with synovial angiogenesis modulators in different forms of knee arthritides.
Gok M., Erdem H., Gogus F., Yilmaz S., Karadag Ö., Simsek I., et al.
Rheumatology international
, cilt.33, sa.4, ss.879-85, 2013 (SCI-Expanded, Scopus)
2008
200858. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis
KISACIK B., Tufan A., KALYONCU U., KARADAĞ Ö., AKDOĞAN A., OZTURK M. A., et al.
JOINT BONE SPINE
, cilt.75, sa.3, ss.291-294, 2008 (SCI-Expanded, Scopus)
2008
200859. Risk of cancer in Turkish patients after treatment with TNF antagonists.
Pay S., Oztürk M. A., Can G., Cefle A., Cobankara V., Erer B., et al.
Rheumatology (Oxford, England)
, cilt.47, sa.4, ss.548-9, 2008 (SCI-Expanded, Scopus)
2007
200760. Accurate diagnosis of acute abdomen in FMF and acute appendicitis patients: how can we use procalcitonin?
Kisacik B., Kalyoncu U., Erol M. F., Karadag Ö., Yildiz M., Akdogan A., et al.
CLINICAL RHEUMATOLOGY
, cilt.26, sa.12, ss.2059-2062, 2007 (SCI-Expanded, Scopus)
2007
200761. Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever
Tufan A., Babaoglu M. O., Akdogan A., Yasar U., Calguneri M., Kalyoncu U., et al.
JOURNAL OF RHEUMATOLOGY
, cilt.34, sa.7, ss.1540-1544, 2007 (SCI-Expanded, Scopus)
2006
200662. Hemorrhage into a thyroid nodule as a cause of thyrotoxicosis.
Onal I. K., Dağdelen S., Atmaca A., Karadağ Ö., Adalar N.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
, cilt.12, sa.3, ss.299-301, 2006 (Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2023
20231. IgG4-Related Pachymeningitis: How Do I Recognize?
ARSLAN D., Yardimci G., BABAOĞLU B., BÖLEK E. Ç., KILIÇ L., Saglam A., et al.
9th Joint ECTRIMS-ACTRIMS meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.656, (Özet Bildiri)
2023
20232. IMPACT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH AS USING BIOLOGIC AGENTS
Uzun G. S., YALÇIN ÇAKIR F., BİLGİN E., Farisogullari B., AYAN G., Ozsoy Z., et al.
European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.1695, (Özet Bildiri)
2023
20233. IDENTIFICATION OF HISTOPATHOLOGIC FINDINGS OF PATIENTS WITH GIANT CELL ARTERITIS: A MULTICENTRE STUDY IN THE ERA OF 2022 ACR/EULAR CLASSIFICATION CRITERIA FOR GCA
Uzun G. S., Gokoz O., Heper A., Ogut B. C., Guresci S., Omma A., et al.
European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.1584-1585, (Özet Bildiri)
2023
20234. PERFORMANCE OF 2022 ACR/EULAR GPA, EGPA AND MPA CLASSIFICATION CRITERIA IN TURKISH VASCULITIS STUDY GROUP PROSPECTIVE COHORT (TRVAS)
Bolek E. C., AYAN G., BİLGİN E., Ediboglu E. D., Duran E., Kardas C., et al.
European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.1597-1598, (Özet Bildiri)
2023
20235. FACTORS ASSOCIATED WITH PERSISTENTLY HIGH HAQ-DI SCORE IN RA PATIENTS UNDER B/ TSDMARDS: LONGITUDINAL ANALYSIS OF HURBIO SINGLE CENTER REGISTRY
BİLGİN E., GÜVEN E., FIRLATAN B., Ekici M., Bayram G. S. K., Unaldi E., et al.
European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.500, (Özet Bildiri)
2023
20236. EVALUATION OF THE EFFECT OF TUMOR NECROSIS FACTOR - A THERAPY ON 24-HOUR AMBULATORY BLOOD PRESSURE MEASUREMENT AND SLEEP QUALITY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS
Moral K., BİLGİN E., KARADAĞ Ö., Kalyoncu U., Akdogan A., Bilgen S. A., et al.
European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, ss.1689, (Özet Bildiri)
2021
20217. Antiretroviral therapy causes a reduction in T-cell exhaustion, which is preserved after switching to a new therapy regimen
Özcan B., Tavukçuoğlu E., KARA E., Horzum U., AYAN G., SÖNMEZER M. Ç., et al.
18th European AIDS Conference (EACS 2021), London, Kanada, 27 Ekim 2021, cilt.1, ss.52-53, (Tam Metin Bildiri)
2021
20218. ROMATOİD ARTRİTLİ BİR HASTADA MEDİASTİNAL KİTLE: LENFOİD KİSTİK TİMİK HİPERPLAZİ
ORAL H., BİLGİN E., YILDIRIM S., ÖNDER S. Ç., DEMİRKAZIK F., UYSAL S., et al.
14. Anadolu Romatoloji Günleri, Online Kongre, 26 - 30 Mayıs 2021, (Özet Bildiri)
2020
20209. CONCOMITANT PSORIATIC ARTHRITIS AND INFLAMMATORY BOWEL DISEASE IN THE PSA BIOLOGICAL REGISTRY: HUR-BIO REAL LIFE RESULTS
Yardimci G. K., Farisogullari B., Armagan B., Bilgin E., Bolek E. C., Duran E., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1174-1175, (Özet Bildiri)
2020
202010. SUBPHENOTYPES IN POLYARTERITIS NODOSA (PAN): TARGET ORGAN ASSOCIATIONS OF A WORLDWIDE COLLABORATION STUDY
Karadag O., Bolek E. C., Furuta S., Emmi G., Hocevar A., Hinojosa-Azaola A., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1060-1061, (Özet Bildiri)
2020
202011. BIOSIMILAR INFLIXIMAB EXPERIENCE IN SPONDYLOARTRITIS PATIENTS: TREASURE REAL LIFE RESULTS
Bilge N. S. Y., Kasifoglu T., Kiraz S., Ertenli A. I., Dalkilic E., Bes C., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1616, (Özet Bildiri)
2020
202012. SECUKINUMAB IS FREQUENTLY PREFERRED IN MULTI ANTI-TNF RESISTANCE SPONDYLOARTHRITIS PATIENTS: HUR-BIO REAL LIFE RESULTS
Armagan B., Kilic L., Yardimci G. K., Bilgin E., Farisogullari B., Bolek E. C., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.419-420, (Özet Bildiri)
2020
202013. LOCALISATION OF RHEUMATOID LUNG NODULES IN PATIENTS WITH RHEUMATOID ARTHRITIS-RELATED INTERSTITIAL LUNG DISEASE: RIGHT OR LEFT?
Bilgin E., Ekici M., Baytar Y., Duran E., Durhan G., Bolek E. C., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.277, (Özet Bildiri)
2020
202014. EMERGING AUTOANTIBODIES PANEL (MYOSITIS ASSOCIATED AND MYOSITIS SPECIFIC ANTIBODIES) IN INFLAMMATORY MYOPATHIES: THE FREQUENCIES OF AND RELATIONSHIP WITH CLINICAL FEATURES
Yardimci G. K., Erul E., Bilgin E., Farisogullari B., Kilic L., Saribas Z., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1605-1606, (Özet Bildiri)
2020
202015. CONCOMITANT USE OF BIOLOGIC DMARDS WITH CSDMARDS INCREASES DRUG RETENTION RATE AND IMPROVES TREATMENT RESPONSE IN THE PSORIATIC ARTHRITIS. HUR-BIO REAL LIFE RESULTS
Duran E., Bilgin E., Bolek E. C., Yardimci G. K., Farisogullari B., Kilic L., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.757, (Özet Bildiri)
2020
202016. CONVENTIONAL SYNTHETIC DMARDS IN PSORIATIC ARTHRITIS - CHANGING PRACTICE IN BIOLOGIC ERA: REAL-LIFE RESULTS FROM HURBIO-PSA REGISTRY
Bilgin E., Duran E., Bolek E. C., Farisogullari B., Yardimci G. K., Kilic L., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1663, (Özet Bildiri)
2020
202017. EFFICACY, RETENTION RATE AND PREDICTORS OF TOFACITINIB EFFICACY AND RETENTION IN RHEUMATOID ARTHRITIS PATIENTS: HUR-BIO REAL-LIFE EXPERIENCE
Bilgin E., Ceylan F., Bolek E. C., Duran E., Farisogullari B., Yardimci G. K., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1460, (Özet Bildiri)
2020
202018. PREDICTORS AND SEVERITY OF POST-THROMBOTIC SYNDROME IN VASCULAR BEHCET'S DISEASE: RETROSPECTIVE MULTICENTER STUDY
Aksoy A., Colak S., Yagiz B., Seniz B. N., Omma A., Yildiz Y., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.367-368, (Özet Bildiri)
2020
202019. FACTORS RELATED TO RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RHEUMATOID ARTHRITIS-RELATED INTERSTITIAL LUNG DISEASE
Kalyoncu U., Ekici M., Bilgin E., Sari A., Baytar Y., Bolek E. C., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1394, (Özet Bildiri)
2020
202020. THE INFLUENCE OF OBESITY ON BIOLOGICAL DMARD TREATMENT RESPONSE IN PSORIATIC ARTHRITIS: HUR-BIO REAL LIFE RESULTS
Farisogullari B., Yardimci G. K., Bolek E. C., Bilgin E., Duran E., Ayan G., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1675-1676, (Özet Bildiri)
2020
202021. INFLAMMATORY ORBITAL DISEASES: THE EXPERIENCE OF A TERTIARY RHEUMATOLOGY CENTRE
Aksun M. S., Sahin T. K., Bolek E. C., Kilic L., Bulut E. G., Oguz K. K., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1806-1807, (Özet Bildiri)
2020
202022. CANCER INCIDENCE AND FEATURES IN ADULT VASCULITIS PATIENTS
Kardas R. C., Bolek E. C., Aktas B. Y., Kilickap S., Karadag O.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.682-683, (Özet Bildiri)
2020
202023. INCIDENCE RATE OF HERPES ZOSTER IN RHEUMATOID ARTHRITIS PATIENTS UNDER TOFACITINIB: REAL-LIFE DATA FROM TURKEY - HURBIO REGISTRY
Bilgin E., Ceylan F., Duran E., Bolek E. C., Farisogullari B., Yardimci G. K., et al.
Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.636, (Özet Bildiri)
2019
201924. Temporal Relationship Between Enteropathic Spondylitis Symptoms/diagnosis and Inflammatory Bowel Diseases Diagnosis: HUR-BIO Real Life Results
FARİSOĞULLARI B., YARDIMCI G. K., SARI A., ARMAĞAN B., BİLGİN E., BÖLEK E. Ç., et al.
2019 ACR/ARP Annual Meeting, 8 - 13 Kasım 2019, (Özet Bildiri)
2019
201925. Amyloidosis in Behcet’s Disease: Experience of a Vasculitis Centre at Silk Road
BÖLEK E. Ç., ERUL M. E., YARDIMCI G. K., KILIÇ L., AKDOĞAN A., KARADAĞ Ö.
2019 ACR/ARP Annual Meeting, ATLANTA, Amerika Birleşik Devletleri, 8 - 13 Kasım 2019, (Özet Bildiri)
2019
201926. Retention Rates and Response of Anti-TNF Treatments in the Enteropathic Spondylitis: HUR-BIO Real Life Results
YARDIMCI G. K., FARİSOĞULLARI B., SARI A., KILIÇ L., ARMAĞAN B., BİLGİN E., et al.
2019 ACR/ARP Annual Meeting, ATLANTA, Amerika Birleşik Devletleri, 8 - 13 Kasım 2019, (Özet Bildiri)
2019
201927. Behçet Hastalığı’nda Hastaların Akdeniz Diyeti Uyumlarının Değerlendirilmesi veAntropometrik Ölçümlerine İncelenmesi: Kesitsel Pilot Çalışma
ERSOY N., BÖLEK E. Ç., Farisoğulları B., BİLGİN E., GARİPOĞLU G., KILIÇ L., et al.
20. Ulusal RomatolojiKongresi, Türkiye, 16 - 20 Ekim 2019, (Özet Bildiri)
2019
201928. Alt ekstremite ağrılarının nadir bir sebebi:Erdheim-Chester hastalığı
DOĞAN Y., BÖLEK E. Ç., KARADAĞ Ö., AKINCI A.
20.ulusal romatoloji kongresi, Türkiye, 16 - 20 Ekim 2019, cilt.11, ss.135, (Tam Metin Bildiri)
2019
201929. Psöriatik artrit hastalar›nda 5 yıllık anti-TNF alfa kullanımı sonrasında subklinik aterosklerozun değişimi
ERDEN A., CANPOLAT U., UYAROĞLU O. A., ÇÖTELİ C., KILIÇ L., AKDOĞAN A., et al.
XX. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, cilt.11, ss.233-234, (Özet Bildiri)
2019
201930. SAT0372 CHANGE OF SUBCLINICAL ATHEROSCLEROSIS AFTER FIVE YEARS ANTI-TNF TREATMENTS IN PSORIATIC ARTHRITIS
ERDEN A., CANPOLAT U., UYAROĞLU O., ÇÖTELİ C., KILIÇ L., AKDOĞAN A., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 Haziran - 15 Aralık 2019, cilt.78, ss.1269, (Özet Bildiri)
2019
201931. AB0574 A MONOGENIC DISEASE WITH WIDE RANGE OF SYMPTOMS: DEFICIENCY OF ADENOSINE DEAMINASE 2
BATU AKAL E. D., TAŞKIRAN Z. E., TEZCAN F. İ., ÖZKARA H. A., ÇAĞDAŞ AYVAZ D. N., ÖZEN S., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1748, (Tam Metin Bildiri)
2019
201932. ENTEROPATHIC ARTHRITIS PATIENTS UNDER BDMARD TREATMENTS HAD FREQUENTLY RADIOGRAPHIC SACROILIITIS: HUR-BIO REAL LIFE RESULTS
YARDIMCI G. K., Farisogullari B., SARI A., KILIÇ L., ARMAĞAN B., BİLGİN E., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.478, (Özet Bildiri)
2019
201933. IS THERE AN OVERLAP OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIDES WITH IGG4-RELATED DISEASE OR NOT?
ERDEN A., BÖLEK E. Ç., YARDIMCI G. K., APRAŞ BİLGEN Ş. Ş., KARADAĞ Ö.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.990, (Özet Bildiri)
2019
201934. OFF-LABEL USE OF BIOLOGICAL THERAPIES IN RELAPSING AND/OR REFRACTORY POLYARTERITIS NODOSA
Canzian A., KARADAĞ Ö., Contis A., Maurier F., Sartorelli S., Denis L., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1186-1187, (Özet Bildiri)
2019
201935. CLINICAL FEATURES OF ANEURYSMAL BEHCET DISEASE
ARMAĞAN B., BÖLEK E. Ç., SARI A., YARDIMCI G. K., Farisogullari B., BİLGİN E., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1182, (Özet Bildiri)
2019
201936. UVEITIS RELATED FACTORS IN PATIENTS WITH SPONDYLOARTHRITIS
Bilge N. S. Y., KAŞİFOĞLU T., KİRAZ S., ERTENLİ A. İ., Kucuksahin O., Dalkilic E., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.491, (Özet Bildiri)
2019
201937. ANEURYSM IN BEHCET'S DISEASE: MANAGEMENT, PROGNOSIS AND MORTALITY
ARMAĞAN B., BÖLEK E. Ç., SARI A., YARDIMCI G. K., Farisogullari B., BİLGİN E., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.422, (Özet Bildiri)
2019
201938. VALIDATION OF A NOVEL DISEASE CLASSIFICATION IN HACETTEPE TAKAYASU ARTERITIS COHORT
BÖLEK E. Ç., DEMİR S., SARI A., KAYA AKCA Ü., KILIÇ L., AKDOĞAN A., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1192, (Özet Bildiri)
2019
201939. COMPARISON OF SURVIVAL RATES AMONG SUBGROUPS OF PATIENTS EVALUATED FOR FEVER OF UNKNOWN ORIGIN
BİLGİN E., ARMAĞAN B., SARI A., BÖLEK E. Ç., Farisogullari B., YARDIMCI G. K., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.573, (Özet Bildiri)
2019
201940. SMOKING MAY BE RELATED TO SACROILIITIS IN ENTEROPATHIC ARTHRITIS PATIENTS: TREASURE REAL-LIFE PRELIMINARY DATA
Kucuksahin O., ERDEN A., Ilgen U., KİRAZ S., ERTENLİ A. İ., Bilge N. S. Y., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1824-1825, (Özet Bildiri)
2019
201941. VALIDATION OF THE GIANT CELL ARTERITIS CLASSIFICATION CRITERIA IN TURKISH PATIENTS
ARMAĞAN B., YILDIRIM A., Onur M., Yardimci G., KILIÇ L., KALYONCU U., et al.
19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri)
2019
201942. VALIDITY OF ACR/EULAR 2017 PROVISIONAL CLASSIFICATION CRITERIA FOR ANCA-ASSOCIATED VASCULITIS IN TURKISH PATIENTS AND COMPARISON WITH 1990 CRITERIA
Yardimci G., BİLGİN E., ARMAĞAN B., Farisogullari B., KILIÇ L., AKDOĞAN A., et al.
19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, ss.39, (Özet Bildiri)
2019
201943. ASSESSMENT OF DAMAGE AND PROGNOSIS IN PATIENTS WITH ADULT IGA VASCULITIS: A RETROSPECTIVE MULTICENTERED COHORT STUDY
Gazel U., Omma A., SARI A., Cansu D. U., YAZICI A., Cefle A. E., et al.
19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri)
2019
201944. CEREBROVASCULAR EVENT CAN BE THE PRESENTING FEATURE OF TAKAYASU ARTERITIS: RESULTS OF A PROSPECTIVE VASCULITIS CENTER
SARI A., BÖLEK E. Ç., KILIÇ L., ARSAVA E. M., TOPÇUOĞLU M. A., KALYONCU U., et al.
19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri)
2019
201945. ARE CHILDHOOD-ONSET AND ADULT-ONSET TAKAYASU ARTERITIS SIMILAR IN TERMS OF CLINICAL FEATURES AND DISEASE COURSE?
Cagri E., Demir B. S., SARI A., KAYA AKCA Ü., KILIÇ L., AKDOĞAN A., et al.
19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, ss.63, (Özet Bildiri)
2019
201946. PEDIATRIC TO ADULT RHEUMATOLOGY CARE TRANSITION PROGRAMME OF HACETTEPE UNIVERSITY: VASCULITIDES PERSPECTIVE
BÖLEK E. Ç., DEMİR S., SARI A., KAYA AKCA Ü., KILIÇ L., AKDOĞAN A., et al.
19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri)
2019
201947. SECONDARY VASCULITIS DUE TO SINGLE GENE DEFECTS
ÖZEN S., BİLGİNER Y., Batu E., KARADAĞ Ö., ALİKAŞİFOĞLU M.
19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, (Özet Bildiri)
2018
201848. Anevrizması olan Behçet hastalar›n tedavisi, prognozu ve mortalitesi
Armagan B., Bolek E. C., SARI A., YARDIMCI G. K., FARİSOĞULLARI B., BİLGİN E., et al.
XIX. Ulusal Romatoloji Kongresi2, Türkiye, 26 - 30 Ekim 2018, (Özet Bildiri)
2018
201849. Evaluation of patients with the diagnosis of vasculitis admitted to a medical ICU
ORTAÇ ERSOY N. E., ÖZEN S., ER B., ÖCAL S., ERDEN A., YARDIMCI G. K., et al.
LIVES, 2018, 20 - 24 Ekim 2018, (Özet Bildiri)
2018
201850. The Existence Of Exosomal MiRNAs In The Circulation In Familial Mediterranean Fever (FMF) Patients
tavukcuoglu z., AKKAYA ULUM Z. Y., YERSAL N., AKBABA T. H., yardimci g. k., karadag o., et al.
EBML Symposia, 3 - 06 Ekim 2018, (Özet Bildiri)
2018
201851. Spinal Cord Involvement in Behcet’xxs Disease-Experience of a Vasculitis Centre at Silk Road
BÖLEK E. Ç., SARI A., KILIÇ L., AKDOĞAN A., TUNCER M. A., KARADAĞ Ö.
ACR 2018, 20 - 24 Ekim 2018, cilt.70, ss.1806, (Tam Metin Bildiri)
2018
201852. Arteriyel anevrizması olan Behçet hastalarnın klinik özellikleri
Armagan B., Bolek E. C., SARI A., YARDIMCI G. K., FARİSOĞULLARI B., BİLGİN E., et al.
XIX. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 26 - 30 Eylül 2018, cilt.10, ss.68-69, (Özet Bildiri)
2018
201853. FREQUENCY OF PULMONARY HYPERTENSION IN BEHCET'S DISEASE
Armagan B., Oksul M., Sener Y. Z., Sari A., Erden A., Yardimci G. K., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1471, (Özet Bildiri)
2018
201854. ANTI-INTERLEUKIN-6 (TOCILIZUMAB) EXPERIENCE IN TAKAYASU'S ARTERITIS PATIENTS
Kilic L., Karadag O., Erden A., Sari A., Armagan B., Firat E., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.437-438, (Özet Bildiri)
2018
201855. IS RELAPSE RATE OF GIANT CELL ARTERITIS IN REAL-LIFE EXPERIENCE LOWER THAN IN THE CONTROLLED TRIALS? RESULTS OF A RETROSPECTIVE, MULTI-CENTRE COHORT STUDY
Alibaz-Oner F., Balci M. A., Pamuk O. N., Zengin O., Tasci M., Dogru A., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1118-1119, (Özet Bildiri)
2018
201856. IDIOPATHIC GRANULOMATOUS MASTITIS MAY RESPONSE WELL TO COMBINATION OF IMMUNOSUPRESIVES AND GLUCOCORTICOIDS
Sari A., Konan A., Akpinar M., Armagan B., Erden A., Kilic L., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1152-1153, (Özet Bildiri)
2018
201857. WHICH ONE IS MORE VALUABLE FOR DIAGNOSIS OF ADULT ONSET STILL'S DISEASE? SOLELY NEUTROPHILIA OR LEUKOCYTOSIS WITH NEUTROPHILIA?
Bilgin E., Erden A., Armagan B., Kilic L., Sari A., Yardimci G., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1150, (Özet Bildiri)
2018
201858. HOW TO DIFFERENTIATE ADULT ONSET STILL'S DISEASE FROM OVERALL OTHER CAUSES OF FEVER OF UNKNOWN ORIGIN: RESULTS OF A PROSPECTIVE STUDY FROM A TERTIARY REFERRAL CENTRE
BİLGİN E., Erden A., Armagan B., KILIÇ L., Sari A., YARDIMCI G. K., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1156-1157, (Özet Bildiri)
2018
201859. RETENTION RATES OF CERTOLIZUMAB PEGOL IN ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS PATIENTS: HUR-BIO REAL LIFE RESULTS
Armagan B., Sari A., Erden A., Yardimci G. K., Kilic L., Kalyoncu U., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1001-1002, (Özet Bildiri)
2018
201860. FOUR YEARS OF DELAY IN THE DIAGNOSIS OF SAPHO SYNDROME: SINGLE TERTIARY CENTRE EXPERIENCE
Erden A., Ekici M., Armagan B., Sari A., Yardimci G. K., Kilic L., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1552, (Özet Bildiri)
2018
201861. ASSESSMENT OF DAMAGE AND PROGNOSIS IN PATIENTS WITH ADULT IGA VASCULITIS: RETROSPECTIVE MULTICENTERED COHORT STUDY
Alibaz-Oner F., Omma A., Sari A., Gazel U., Cansu D. U., YAZICI A., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1474-1475, (Özet Bildiri)
2018
201862. PSAID-12 CAN BE USED TO DETERMINE THE ANTI-TNF TREATMENT DECISION IN THE PSORIATIC ARTHRITIS REGISTRY
Kalvoncu U., Kiraz S., Bilgen S. A., Karadag O., Akdogan A., Kilic L., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1601-1602, (Özet Bildiri)
2018
201863. COMPARISON OF CUT-OFF VALUES FOR FERRITIN TO DISCRIMINATE ADULT ONSET STILL'S DISEASE FROM OTHER CAUSES OF FEVER OF UNKNOWN ORIGIN: RESULTS OF A PROSPECTIVE STUDY
Bilgin E., Erden A., Armagan B., Kilic L., Sari A., Yardimci G., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.1675, (Özet Bildiri)
2018
201864. POLYARTERITIS NODOSA: OVER 20 YEARS' CLINICAL EXPERIENCE
Sonmez H. E., Armagan B., Ayan G., BARUT K., Batu E. D., Erden A., et al.
Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.775-776, (Özet Bildiri)
2017
201765. ANKİLOZAN SPONDİLİTTE EKLEM MOBİLİTESİNİN BİREYLERİN SAĞLIK ALGISINA ETKİSİNİN İNCELENMESİ
ARIN G., TÜRKMEN N. B., OFLAZ F. B., ERDEN A., KARADAĞ Ö., GÖKSÜLÜK D., et al.
3.Ulusal Romatolojik Rehabilitasyon Kongresi, Türkiye, 6 - 08 Ekim 2017, cilt.4, (Özet Bildiri)
2017
201766. Which Definition Should be Used to Determine Colchicine Resistance in Patients with Familial Mediterranean Fever?
ERDEN A., BATU E. D., SARI A., SÖNMEZ H. E., ARMAĞAN B., FIRAT E., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
2017
201767. A Retrospective Study Comparing the Phenotype and Outcomes of Patients with Polyarteritis Nodosa between UK and Turkish Cohorts
KARADAĞ Ö., ERDEN A., BİLGİNER Y., GOPALUNI S., SARI A., ARMAĞAN B., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
2017
201768. Older Age and Male Gender Are Independent Predictors of Quantiferon Positivity Among Adult Rheumatic Patients in a Tertiary Care Center from a BCG Vaccinated Country: Hur-BIO Single Center Real Life Results
ŞEYHOĞLU E., UYAROĞLU O. A., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
2017
201769. Pregnancy Outcomes in Male Patients Using Anti-Tumor Necrosis Factor Alpha Patients with Inflammatory Arthritis Hur-BIO Real Life Experiences
UYAROĞLU O. A., ŞEYHOĞLU E., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
2017
201770. Starting of Biological Dmards May be Postponed in RA Patients with Multimorbidity: Single Centre Real Life Results
ARMAĞAN B., SARI A., ERDEN A., KILIÇ L., ERDAT E. C., KARADAĞ Ö., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
2017
201771. Patients with Ankylosing Spondylitis Had Better Adalimumab Survival Than Patients with Non-Radiographic Axial Spondyloarthritis
SARI A., ARMAĞAN B., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.
2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)
2017
201772. Sjögren Sendromu’nun Kas Güçsüzlüğü ile Prezantasyonu: Renal Tubuler Asidoz Tip 1
BÖLEK E. Ç., ERDEN A., KOÇ H., KARADAĞ Ö., KALYONCU U., KİRAZ S., et al.
19.Ulusal İç Hastalıkları Kongresi, Türkiye, 11 - 15 Ekim 2017, (Tam Metin Bildiri)
2017
201773. Distribution of vasculitides in Eastern mediteranean: Results of a prospective cohort
KARADAĞ Ö., ERDEN A., BATU E. D., BİLGİN E., UYAROGLU o., ŞEYHOĞLU E., et al.
EUROPEAN LEAGUE AGAİNST RHEUMATOLOGY ANNUAL MEETİNG 2017, 14 - 17 Haziran 2017, (Tam Metin Bildiri)
2017
201774. A Section of Rare Diseases in Hacettepe Adult Clinics in Rheumatology: Deficiency of Adenosine Deaminase 2 (DADA2)
BÖLEK E. Ç., ERDEN A., ÖZEN S., KARADAĞ Ö., KALYONCU U., BATU E. D., et al.
5th Rare Diseases Summer School, 7 - 09 Haziran 2017, (Tam Metin Bildiri)
2017
201775. PREMATURE CORONARY HEART DISEASE FREQUENCY IN RHEUMATOID ARTHRITIS WHO ARE RECEIVING BIOLOGIC AGENTS: HUR-BIO REAL LIFE RESULTS
Armagan B., Sari A., Erden A., Kilic L., Erdat E. C., Karadag O., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.250-251, (Özet Bildiri)
2017
201776. ADHERENCE OF RHEUMATIC PATIENTS TO INH PROPHYLAXIS PRESCRIBED BEFORE BIOLOGICAL TREATMENT: HUR-BIO SINGLE CENTER REAL LIFE RESULTS
Seyhoglu E., Uyaroglu O. A., Erden A., Kilic L., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1035, (Özet Bildiri)
2017
201777. PSORIASIS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER
Erden A., Batu E. D., Bilgin E., Sonmez H. E., Seyhoglu E., Demir S., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.414, (Özet Bildiri)
2017
201778. THORAX CT FINDINGS IN A LARGE COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS: HUR-BIO REAL LIFE RESULTS
Sari A., Armagan B., Erden A., Kilic L., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.256, (Özet Bildiri)
2017
201779. ABATACEPT EXPERIENCE IN BIOLOGIC NAIVE RHEUMATOID ARTHRITIS PATIENTS: HUR-BIO REAL LIFE RESULTS
Sari A., Armagan B., Kilic L., Erden A., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.854-855, (Özet Bildiri)
2017
201780. DISTRIBUTION OF VASCULITIDES IN EASTERN MEDITERRANEAN: RESULTS OF A PROSPECTIVE COHORT
Karadag O., Erden A., Batu E. D., Bilgin E., Uyaroglu A. O., Seyhoglu E., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.616, (Özet Bildiri)
2017
201781. . IGG4-RELATED DISEASE IN EASTERN MEDITERRANEAN: CLINICAL FEATURES AND OUTCOMES OF A LARGE COHORT
KARADAĞ Ö., ERDEN A., AYHAN E. A., BÖLEK E. Ç., ARMAĞAN B., KILIÇ L., et al.
EULAR 2017, 6 - 10 Haziran 2017, cilt.76, ss.720, (Özet Bildiri)
2017
201782. THERE IS A COMMUNICATION PROBLEM BETWEEN PATIENT AND PHYSICIAN DURING PRE-CONCEPTIONAL PERIOD: HUR-BIO REAL LIFE RESULTS
Uyaroglu O. A., Seyhoglu E., Erden A., Kilic L., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.448, (Özet Bildiri)
2017
201783. ANKYLOSING SPONDYLITIS PATIENTS WITH UVEITIS HAD BETTER ADALIMUMAB RETENTION RATE: HUR-BIO REAL LIFE RESULTS
Armagan B., Sari A., Erden A., Kilic L., Guven D. C., Pashayev T., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1300-1301, (Özet Bildiri)
2017
201784. RAID COMPOSITE INDEX IN THE EVALUATION OF RA PATIENTS RECEIVING BIOLOGICAL TREATMENT: HUR-BIO REAL-LIFE RESULTS
Erden A., Kilic L., Armagan B., Sari A., Akdogan A., Bilgen S. A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1113, (Özet Bildiri)
2017
201785. COMORBIDITY AND SURGERY HISTORY OF RHEUMATOID ARTHRITIS PATIENTS WHO ARE RECEIVING BIOLOGICAL AGENT
Armagan B., Sari A., Erden A., Kilic L., Erdat E. C., Karadag O., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.534, (Özet Bildiri)
2017
201786. WIDE HETEROGENEITY IN TREATMENT PROTOCOLS AND INAPPROPIATE USE OF PREDNISOLONE FOR ANTI-RO/LA ASSOCIATED-CONGENITAL HEART BLOCK: A SYSTEMATIC REVIEW OF 492 CASES
Erden A., Kilic L., Bilgin E., Fanouriakis A., Ceylan S., Hyrnabaccus B., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1215-1216, (Özet Bildiri)
2017
201787. THERAPEUTIC PLASMA EXCHANGE (TPE) FOR REFRACTORY SLE: A COMPARISON OF OUTCOMES BETWEEN DIFFERENT SUB-PHENOTYPES?
Soyuoz A., Karadag O., Kilic L., Akyol T. K., Bilgen S. A., Ozcebe O. I.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1212, (Özet Bildiri)
2017
201788. FUNCTIONAL DISABILITY IN RA PATIENTS TREATED WITH BIOLOGICS: HUR-BIO REAL LIFE RESULTS
Sari A., Armagan B., Erden A., Kilic L., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1127, (Özet Bildiri)
2017
201789. ARE THE DEMOGRAPHIC AND CLINICAL FEATURES OF POLYARTERITIS NODOSA SIMILAR BETWEEN THE UK AND TURKEY?
Karadag O., Erden A., Batu E. D., Gopaluni S., Sari A., Armagan B., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.329, (Özet Bildiri)
2017
201790. THE USE OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: IN WHICH INFUSION INTERVALS WERE GIVEN AND HOW DID THEY RESPOND? HUR-BIO REAL LIFE RESULTS
Armagan B., Sari A., Erden A., Kilic L., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1194-1195, (Özet Bildiri)
2017
201791. QUANTIFERON (R)-TB GOLD IN-TUBE ASSAY CAN BE USED FOR LATENT TUBERCULOSIS SCREENING BEFORE BIOLOGICAL DRUG TREATMENT IN A BCG VACCINATED COUNTRY: HUR-BIO SINGLE CENTER REAL LIFE RESULTS
Seyhoglu E., Uyaroglu O. A., Erden A., Kilic L., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1412-1413, (Özet Bildiri)
2017
201792. PRESENTATION OF A NEW SCALE ASSESSING THE BIOPSYCHOSOCIAL ASPECTS OF HEALING PROPERTIES IN RHEUMATIC PATIENTS
ÜNAL E., KISACIK P., Arin G., KARABULUT E., GÖKSÜLÜK D., Yagli N. V., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.1531, (Özet Bildiri)
2017
201793. IS THERE ANY ROLE OF IMMUNOGENICITY ON THE RESPONSE TO THE ANTI-TUMOR NECROSIS FACTOR ALPHA THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS: THE FIRST RESULTS OF A PROSPECTIVE COHORT STUDY
Akar S., Cinar M., Sargin G., Karadag O., Kinikli G., Ozmen M., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.354, (Özet Bildiri)
2017
201794. BIOLOGICAL THERAPY IN NON-SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS PATIENTS FOLLOWED IN ADULT RHEUMATOLOGY DEPARTMENT: HUR-BIO REAL LIFE RESULTS
Kilic L., Sari A., Armagan B., Erden A., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.402, (Özet Bildiri)
2017
201795. Comorbidity and Surgery History of Rheumatoid Arthritis Patients Who Receiving Biological Agent
ARMAĞAN B., SARI A., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.
MIRCIM 2017 TIHUD-TIP JOINT MEETING, Krakow, Polonya, 11 - 14 Mayıs 2017, (Özet Bildiri)
2017
201796. SCALP NECROSIS IN NEUROFIBROMATOSIS TYPE-1 VASCULOPATHY: A DIAGNOSTIC DILEMMA
Guven D., SARI A., ARMAĞAN B., KİRAZ S., KILIÇ L., KARADAĞ Ö., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.101-102, (Özet Bildiri)
2017
201797. ASSESSMENT OF PROGNOSIS AND DAMAGE IN PATIENTS WITH ADULT HENOCH SCHONLEIN PURPURA RETROSPECTIVE MULTICENTERED COHORT STUDY
ALİBAZ ÖNER F., ALİBAZ ÖNER F., Omma A., SARI A., KARADAĞ Ö., Cansu D. U., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.85-86, (Özet Bildiri)
2017
201798. TWO-YEAR RESULTS OF A PROSPECTIVE VASCULITIS COHORT FROM EASTERN MEDITERRANEAN: DEMOGRAPHIC CHARACTERISTICS AND DISTRIBUTION OF THE VASCULITIDES FREQUENCIES
KARADAĞ Ö., APRAŞ BİLGEN Ş. Ş., ARMAĞAN B., SARI A., ERDEN A., BATU AKAL E. D., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, (Özet Bildiri)
2017
201799. LEUKOCYTOCLASTIC VASCULITIS IN THE BONE MARROW
SARI A., ARMAĞAN B., ERDEN A., KILIÇ L., Ayhan A. S., KARADAĞ Ö.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.72, (Özet Bildiri)
2017
2017100. EVALUATION OF ASSSOCIATION BETWEEN ANTIPHOSPHOLIPID ANTIBODIES OR LUPUS ANTICOAGULANT POSITIVITY AND SEVERITY OF VASCULAR INVOLVEMENT IN TAKAYASU ARTERITIS PATIENTS
FIRAT E., ERDEN A., SARI A., ARMAĞAN B., KILIÇ L., KALYONCU U., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.48, (Özet Bildiri)
2017
2017101. SUCCESSFUL TREATMENT OF AORTOENTERIC FISTULA A PATIENT WITH BEHCET DISEASE INTERFERON ALFA2A AND SURGERY
ARMAĞAN B., SARI A., ERDEN A., KILIÇ L., KALYONCU U., KARADAĞ Ö.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.94, (Özet Bildiri)
2016
2016102. OPHTALMOLOGIC FINDINGS IN PATIENTS WITH TAKAYASU'S ARTERITIS
Kelesoglu A. B., Baytaroglu A., Sari A., Erden A., Kilic L., Tatar O., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, ss.1101-1102, (Özet Bildiri)
2016
2016103. COMPARING THE CHARACTERISTICS OF ADULT AND PEDIATRIC PATIENTS WITH POLYARTERITIS NODOSA
Erden A., Batu E. D., Bilgin E., Sonmez H. E., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.799, (Özet Bildiri)
2016
2016104. DEMOGRAPHIC CHARACTERISTICS AND DISTRIBUTION OF THE VASCULITIDES FREQUENCIES: A REAL-LIFE EXPERIENCE OF VASCULITIS CENTER FROM EASTERN MEDITERRANEAN
Karadag O., Erden A., Bilgin E., Batu E. D., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1096-1097, (Özet Bildiri)
2016
2016105. COMMON AND UNCOMMON MANIFESTATIONS OF GRANULOMATOSIS WITH POLIANGIITIS (GPA) AT CHEST CT: A VASCULITIS CENTER EXPERIENCE
Taydas O., Kilic L., Atceken Z., Erden A., Armagan B., Sari A., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.796, (Özet Bildiri)
2016
2016106. DEMOGRAPHIC, CLINIC AND LABORATORY FEATURES OF 755 PATIENTS WITH NEONATAL LUPUS ERYTHEMATOSUS: SYSTEMATIC REVIEW
Erden A., Kilic L., Bilgin E., Ceylan S., Hymabaccus B., Sener Y. Z., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.874, (Özet Bildiri)
2016
2016107. DAPSA WITH TWENTY-EIGHT JOINT COUNTS MAY BE USEFUL FOR THE ASSESSMENT OF PSORIATIC ARTHRITIS
Kalyoncu U., Erden A., Kilic L., Sari A., Armagan B., Karadag O., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1159-1160, (Özet Bildiri)
2016
2016108. RITUXIMAB SEEMS OUTSTANDING BIOLOGICAL OPTION IN LATE ONSET RHEUMATOID ARTHRITIS: HUR-BIO REAL LIFE RESULTS
Kilic L., Erden A., Sari A., Armagan B., Karadag O., Akdogan A., et al.
Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1022-1023, (Özet Bildiri)
2015
2015109. THE RHEUMATOLOGIST'S PERSPECTIVE IN DIAGNOSTIC COURSE AND MANAGEMENT OF FAMILIAL MEDITERRANEAN FEVER
Karadag O., Kilic L., Erden A., Kasifoglu T., Karaaslan Y., Kiraz S., et al.
18th ISPOR Annual European Congress, Milan, İtalya, 7 - 11 Kasım 2015, cilt.18, (Özet Bildiri)
2015
2015110. Comorbidities in patients with Familial Mediterranean Fever
B Balci P., ARICI Z. S., Avcı E., BATU E. D., Arslanoğlu E., Burak Ç., et al.
8th International congressof familial mediterranean fever and systemic autoinflammatory diseases, 30 Eylül - 03 Ekim 2015
2015
2015111. Malignancy risk in systemic Lupus Erythematosus patients treated with cyclophosphamide
Yilmaz N., Emmungil H., Gucenmez S., Ozen G., Yildiz F., Balkarli A., et al.
11th International Congress on Systemic Lupus Erythematosus, Vienna, Avusturya, 2 - 06 Eylül 2015, cilt.33, (Özet Bildiri)
2014
2014112. INCREASED EPICARDIAL ADIPOSE TISSUE IN PATIENTS WITH SYSTEMIC SCLEROSIS
Yilmaz N., Baysal E., Karadag O.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.563, (Özet Bildiri)
2014
2014113. RETROPERITONEAL FIBROSIS, IGG4-RELATED DISEASES AND CARDIOVASCULAR FIBROSCLEROSIS
Karadag O., Kalyoncu U., Kilic L., Helvaci O., Sener Y. Z., Akdogan A., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.1108-1109, (Özet Bildiri)
2014
2014114. RETRO-ORBITAL GRANULOMA IN GRANULOMATOSIS WITH POLYANGIITIS
Bitik B., Kilic L., Kucuksahin O., Sahin K., Mercan R., Tufan A., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.550, (Özet Bildiri)
2014
2014115. THE COMPARATIVE ONE-YEAR DRUG SURVIVAL RATE OF TUMOR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS; RESULTS FROM TURKBIO REGISTRY
Sari I., Kalyoncu U., Onat A. M., Pamuk O. N., Karadag O., Kisacik B., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.425, (Özet Bildiri)
2014
2014116. FREQUENCY OF RADIOLOGICAL HIP INVOLVEMENT AND TOTAL HIP REPLACEMENT IN A LARGE SINGLE CENTER SPONDYLOARTHRITIS COHORT WITH BIOLOGICAL TREATMENTS: HUR-BIO REAL LIFE RESULTS
Kalyoncu U., Karadag O., Kilic L., Ertenli I., Bilgen S. A., Akdogan A., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.726, (Özet Bildiri)
2014
2014117. EVALUATION OF SYSTEMIC SCLEROSIS PATIENTS BY QUANTITATIVE SENSORY TESTING FOR THE PRESENCE OF NEUROPATHY
Kilic L., Akdogan A., Karadag O., Kalyoncu U., Bilgen S. A., Ertenli I., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.660, (Özet Bildiri)
2014
2014118. THE PATIENT-DERIVED PSA IMPACT OF DISEASE (PSAID) QUESTIONNAIRE CORRELATES WITH OTHER OUTCOME MEASURES: HUR-BIO REAL LIFE RESULTS
Kilic L., Karadag O., Gossec L., Bilgen S. A., Akdogan A., Kiraz S., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.739, (Özet Bildiri)
2014
2014119. SHORT TERM EFFICACY OF TUMOR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLARTHRITIS AND ANKYLOSING SPONDYLITIS; RESULTS FROM TURKBIO REGISTRY
Cetin P., Kalyoncu U., Solmaz D., Sari I., Karadag O., Kilic L., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.724, (Özet Bildiri)
2014
2014120. PATIENTS WITH ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS HAD SIMILAR TNFI DRUG SURVIVAL: HUR-BIO REAL LIFE RESULTS
Kalyoncu U., Karadag O., Kilic L., Bilgen S. A., Akdogan A., Kiraz S., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.718, (Özet Bildiri)
2014
2014121. THERAPEUTIC PLASMA EXCHANGE (TPE) FOR REFRACTORY AUTOIMMUNE DISEASES: REPORT OF 60 CASES
Karadag O., Soyuoz A., Kalyoncu U., Karaagac T., Kilic L., Kiraz S., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.528-529, (Özet Bildiri)
2014
2014122. PATIENTS WITH PSORIATIC ARTHRITIS HAD BETTER TNFI SURVIVAL THAN ANKYLOSING SPONDYLITIS: HUR-BIO REAL LIFE RESULTS
Kalyoncu U., Karadag O., Kilic L., Bilgen S. A., Akdogan A., Kiraz S., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.744, (Özet Bildiri)
2014
2014123. RETENTION RATE OF TNF BLOCKERS IS GREATER IN CASE OF ADVANCED SPINAL ANKYLOSIS IN AXIAL SPONDYLOARTHRITIS: DATA FROM THE HUR-BIO REGISTRY
Kalyoncu U., Kilic L., Karadag O., Bilgen S. A., Akdogan A., Kiraz S., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.727, (Özet Bildiri)
2014
2014124. RISK FACTORS OF ADVANCED SPINAL DISEASE AND/OR BAMBOO DISEASE IN PATIENTS WITH ANKYLOSING SPONYLITIS DURING TNFI TREATMENTS: HUR-BIO REAL LIFE RESULTS
Kalyoncu U., Karadag O., Kilic L., Ertenli I., Bilgen S. A., Akdogan A., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.213, (Özet Bildiri)
2014
2014125. FAMILY HISTORY IN TURKISH ANKYLOSING SPONDYLITIS PATIENTS RECEIVING ANTI-TNF THERAPY
Kalyoncu U., Cetin P., Karadag O., Sari I., Kilic L., Ertenli I., et al.
15th Annual European Congress of Rheumatology (EULAR), Paris, Fransa, 11 - 14 Haziran 2014, cilt.73, ss.435-436, (Özet Bildiri)
2013
2013126. Quantiferon-TB Test Can Be Usefull For Decision Of Anti-Tuberculosis Prophylaxis During Anti-TNF Treatment: Result Of Real Life
KALYONCU U., KILIÇ L., İNKAYA A. Ç., KARADAĞ Ö., Bilgen S. A., AKDOĞAN A., et al.
77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri)
2013
2013127. AB0589 SUBCLINICAL ATHEROSCLEROSIS FOUND BOTH IN PSORIATIC ARTHRITIS AND RHEUMATOID ARTHRITIS
APRAŞ BİLGEN Ş. Ş., KALYONCU U., KILIÇ L., KARADAĞ Ö., CANPOLAT U., AYTEMİR K., et al.
European League Against Rheumatism (EULAR) Congress, 12-15 June, 2013; Madrid-Spain., 12 - 15 Haziran 2013
2013
2013128. AB0430 WHAT IS THE ROLE OF AMBULATORY BLOOD PRESSURE MONITORING IN SLE
ER E., AKDOĞAN A., KILIÇ L., CANPOLAT U., KAYA E. B., KARADAĞ Ö., et al.
European League Against Rheumatism (EULAR) Congress, 12-15 June, 2013; Madrid-Spain., 12 - 15 Haziran 2013
2012
2012129. CROSS-Sectional Assessment of Damage in Takayasu Arteritis with A Validated Tool.
Omma A., Erer B., KARADAĞ Ö., Yilmaz N., ALİBAZ ÖNER F., Yildiz F., et al.
Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 Kasım 2012, cilt.64, (Özet Bildiri)
2011
2011130. THE RATE AND CAUSES OF SWITCHING AMONG THE RHEUMATIC PATIENTS UNDER BIOLOGIC THERAPY: FINDINGS FROM TURKISH RHEUMATOLOGY DATABASE-ROMADIGITAL
Karadag O., Yilmaz S., Kisacik B., KALYONCU U., Tezcan E., YILMAZ S., et al.
Conference on Excellence in Rheumatology, İstanbul, Türkiye, 17 - 19 Şubat 2011, cilt.50, (Özet Bildiri)
2007
2007131. MEFV mutations frequency and effect on disease severity in ankyloing spondylitis
Maras Y., Calguneri M., Akdogan A., Karadag O., Kalyoncu U., Ovunc B., et al.
Annual European Congress of Rheumatology (EULAR 2007), Barcelona, İspanya, 13 - 16 Haziran 2007, cilt.66, ss.400, (Özet Bildiri)
2006
2006132. Ankylosing spondylitis has a more severe disease course when coexist with Familial Mediterranean Fever.
Calguneri M., Kalyoncu U., Akdogan A., Karadag O., Maras Y., Kisacik B., et al.
70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Washington, Kiribati, 10 - 15 Kasım 2006, cilt.54, ss.4050-4051, (Özet Bildiri)
2006
2006133. A comparison of effects of active physiotheraphy and home exercise programs in patients with osteoarthritis of the shoulder
Yakut E., Yagli N. V., Kiraz S., Akdogan A., Kalyoncu U., Yakut Y., et al.
Annual European Congress of Rheumatology (EULAR 2006), Amsterdam, Hollanda, 21 - 24 Haziran 2006, cilt.65, ss.411, (Özet Bildiri)
2006
2006134. Drug transporter gene MDR1 polymorphism C3435T may explain colchicine nonresponsiveness in familial Mediterranean fever
Tufan A., Babaoglu M., Akdogan A., Yasar U., Calguneri M., Kalyoncu U., et al.
Annual European Congress of Rheumatology (EULAR 2006), Amsterdam, Hollanda, 21 - 24 Haziran 2006, cilt.65, ss.100, (Özet Bildiri)
2006
2006135. Serum lipid changes and effect of colchicine on serum lipids in FMF
Akdogan A., Kalyoncu U., Tufan A., Karadag O., Calguneri M., Eren S., et al.
Annual European Congress of Rheumatology (EULAR 2006), Amsterdam, Hollanda, 21 - 24 Haziran 2006, cilt.65, ss.264, (Özet Bildiri)
2006
2006136. Anti TNF treatment may induce EBV reactivation in RA patients A clue for increased risk of lymphoma
TOKGÖZOĞLU S. L., ERTENLİ A. İ., KALYONCU U., ALP A., KARADAĞ Ö., ERMAN M., et al.
Annual European Congress of Rheumatology (EULAR 2006), 21 - 24 Haziran 2006, (Tam Metin Bildiri)
2005
2005137. QT dispersion increases in patients with systemic lupus erythematosus
Yavuz B., Karadag O., Tulumen E., Calguneri M., Atalar E., Ovunc K., et al.
Annual European Congress of Rheumatology, Vienna, Avusturya, 8 - 11 Haziran 2005, cilt.64, ss.237-238, (Özet Bildiri)
2005
2005138. B-type natriuretic peptide (BNP) is useful for detecting diastolic dysfunction in patients with systemic lupus erythematosus
Karadag O., Yavuz B., Calguneri M., Akdogan A., Atalar E., Ovunc K., et al.
Annual European Congress of Rheumatology, Vienna, Avusturya, 8 - 11 Haziran 2005, cilt.64, ss.237, (Özet Bildiri)
2005
2005139. Novel cardiovascular risk factors and cardiac event predictors in systemic lupus erythematosus
Karadag O., Calguneri M., Yavuz B., Akdogan A., Atalar E., Kalyoncu U., et al.
Annual European Congress of Rheumatology, Vienna, Avusturya, 8 - 11 Haziran 2005, cilt.64, ss.237, (Özet Bildiri)
2005
2005140. The correlations of plasma inflammatory markers and anti-nucleosome antibodies with SLEDAI
Kalyoncu U., Akdogan A., Calguneri M., Karadag O., Kisacik B., Apras S., et al.
Annual European Congress of Rheumatology, Vienna, Avusturya, 8 - 11 Haziran 2005, cilt.64, ss.237, (Özet Bildiri)
2005
2005141. Biochemical markers of bone turnover in the diagnosis of myeloma bone disease.
Dizdar O., Barista I., Kalyoncu U., Karadag O., Celik I., Kars A., et al.
41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 13 - 17 Mayıs 2005, cilt.23, (Özet Bildiri)
2004
2004142. Neutrophil CD64 expression in Behqet's disease
Ureten K., Ertenli I., Calguneri M., Ozturk M., Onat A., Akdogan A., et al.
Annual European Congress of Rheumatology (EULAR 2004), Berlin, Almanya, 9 - 12 Haziran 2004, cilt.63, ss.316, (Özet Bildiri)
Desteklenen Projeler
2018 - 2020
2018 - 2020Behçet Hastalığında Ön Segment Yapılarının In Vivo Konfokal Mikroskopi ile Hücresel Düzeyde İncelenmesi
Yükseköğretim Kurumları Destekli Proje , BAP Alt Yapı
DİKMETAŞ SANDIKÇI Ö. (Yürütücü), İRKEÇ M. T., KARADAĞ Ö., KOCABEYOĞLU S.
2013 - 2017
2013 - 2017Ailevi Akdeniz ateşinde sakroileit varlığının genetik temelinin araştırılması
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
KARADAĞ Ö. (Yürütücü)